Gambogenic acid
CAS No. 173932-75-7
Gambogenic acid ( GNA )
Catalog No. M12639 CAS No. 173932-75-7
Gambogenic acid (GNA) is a polyprenylated xanthone isolated from gamboge.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 197 | Get Quote |
|
10MG | 340 | Get Quote |
|
25MG | 561 | Get Quote |
|
50MG | 794 | Get Quote |
|
100MG | 1062 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGambogenic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionGambogenic acid (GNA) is a polyprenylated xanthone isolated from gamboge.
-
DescriptionGambogenic acid (GNA) is a polyprenylated xanthone isolated from gamboge, shows potent antitumor activity and can effectively inhibit the survival and proliferation of cancer cells; specifically and covalently binds to Cys668 within the EZH2-SET domain, trigges EZH2 degradation (IC50=8.6 uM) through COOH terminus of Hsp70-interacting protein (CHIP)-mediated ubiquitination; synergistically potentiates bortezomib-induced apoptosis in multiple myeloma; also induces proteasomal degradation of CIP2A and sensitizes hepatocellular carcinoma to anticancer agents.
-
SynonymsGNA
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number173932-75-7
-
Formula Weight630.78
-
Molecular FormulaC38H46O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)/C(C)=C\C[C@]([C@@]12OC3=C4C(O)=C(C/C=C(C)/CC/C=C(C)\C)C(O)=C3C/C=C(C)\C)(OC(C)(C)[C@]2([H])C5)C([C@]5([H])C=C1C4=O)=O
-
Chemical Name(Z)-4-((1S,3aR,5S,12aS)-9-((E)-3,7-dimethylocta-2,6-dien-1-yl)-8,10-dihydroxy-2,2-dimethyl-11-(3-methylbut-2-en-1-yl)-4,7-dioxo-1,2,5,7-tetrahydro-1,5-methanofuro[2,3-d]xanthen-3a(4H)-yl)-2-methylbut-2-enoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xu L, et al. Cell Death Dis. 2018 Feb 15;9(3):262.
2. Liu P, et al. J Cancer. 2017 Sep 16;8(16):3278-3286.
3. Wang X, et al. EMBO J. 2017 May 2;36(9):1243-1260.
4. Li F, et al. Exp Ther Med. 2017 May;13(5):2456-2462.
2. Liu P, et al. J Cancer. 2017 Sep 16;8(16):3278-3286.
3. Wang X, et al. EMBO J. 2017 May 2;36(9):1243-1260.
4. Li F, et al. Exp Ther Med. 2017 May;13(5):2456-2462.
molnova catalog
related products
-
BRD-4770
A SAM mimetic that selectively inhibits a subset of Histone Methyltransferase (HMTs).
-
UNC0224
A potent, selective G9a/GLP inhibitor with IC50 of 57 nM and 58 nM CLOT biochemical assays.
-
MM-102 trifluoroacet...
A high-affinity, small-molecule peptidomimetic inhibitor of MLL1/WDR5 protein-protein interaction with Ki of 2.4 nM.